|
Match
|
Document |
Document Title |
|
|
5348739 |
Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H2 -receptor agonists
A method of inhibiting the development of malignant tumors and the formation of metastases of malignant tumor cells in a subject carrying the comprises administering to the subject IL-2 and an...
|
|
|
5346887 |
Glaucoma treatment
A method and a composition for treating or reducing and/or controlling intraocular pressure comprising administering an effective amount of a renin inhibiting compound of the formula: ##STR1##...
|
|
|
5338740 |
Angiotensin II receptor antagonists
The present invention relates to novel heterocyclic derivatives of the formula Ar--W--Hetwherein Ar, W and Het are as defined below, and related compounds, pharmaceutical compositions comprising...
|
|
|
5338749 |
Diaryl-substituted heterocyclic compounds, their preparation and drigs and cosmetics obtained therefrom
Compounds of formula I ##STR1## and compounds of formula Ia ##STR2## where the substituents are as defined in the specification.
|
|
|
5326762 |
Inhibitors of acyl-coenzyme A: cholesterol acyl transferase
Amides of the formula ##STR1## wherein R1 and R2 are independently heteroaryl, X-substituted heteroaryl, X-substituted phenyl, N-substituted triazinyl or N-substituted imidazolyl; and in addition,...
|
|
|
5324728 |
Naphthoic acid derivative
A naphthoic acid derivative represented by the following general formula or a salt thereof: ##STR1## wherein R1, R2 and R3 are each independently a hydrogen atom, a halogen atom, a hydroxyl group,...
|
|
|
5321039 |
Method of inducing a histamine agonist action on H2 receptors
The invention claims as drugs which are active as agonists of the histamine H3 receptor, the O-[2-(4(5-imidazolyl)-ethyl] isothiourea, 4-(4(5)-imidazolyl) butyramidine and...
|
|
|
5312828 |
Substituted imidazoles having angiotensin II receptor blocking activity
Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma,...
|
|
|
5302610 |
Renal-selective biphenylmethyl imidazole angiotensin II antagonists for treatment of hypertension
Renal-selective compounds are described which, in one embodiment, are prodrugs preferentially converted in the kidney to compounds capable of blocking angiotensin II (AII) receptors. These prodrugs...
|
|
|
5296493 |
1-substituted-2-(N-pheny l-N-(phenylmethyl)methanamine)-4,5-dihydro-imidazoles and related compounds and their use in treating calcium overload in brain cells
The present patent application discloses compounds of the formula ##STR1## wherein R1 is C1-10 saturated or unsaturated alkyl; or ##STR2## wherein R'" is H or ##STR3## R2 is phenyl which is...
|
|
|
5294440 |
Composition for treatment of cold sores
A pharmaceutical composition of water, water soluble vinyl polymer gel, amine alcohol dispersant and 1H-imidazole-4-ethanamine, phosphate (IEP) is used topically to treat herpes labialis lesions.
|
|
|
5294634 |
Osteogenesis promoter
The present invention relates to an orally-administrable osteogenesis promoter, which comprises, as an active ingredient, a zinc salt or complex of L-carnosine, has excellent...
|
|
|
5292887 |
Substituted imidazole derivatives and their preparation and use
Compounds of the formula: ##STR1## wherein X is --CH2 -- or ##STR2## R1 is H, C1-5 -alkyl or benzyl, which can be substituted or unsubstituted R2 is H, C1-4 -alkyl, OH or C1-3 -alkoxy R3 is H, CH3,...
|
|
|
5292755 |
USPA benzolyguanidines
Benzoylguanidines of the formula I ##STR1## where R(1) or R(2) is equal to R(6)--S(O)n -- or R(7)R(8)N--O2 S-- and the other substituent R(1) or R(2) is in each case equal to H, F, Cl, Br, I,...
|
|
|
5286739 |
Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
An anti-hypotensive formulation comprising an essentially arginine-free or low arginine (less than about 0.1%, most preferably, about 0.01%) containing mixture of amino acids is provided. The...
|
|
|
5284645 |
Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
Disclosed are fluorocarbon emulsions comprising amino acids and substances related to amino acids, such as substituted amino acids or amphoteric groups of amino acid side chains, for example, the...
|
|
|
5284876 |
Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents
This invention pertains to a method for treating a subject for Tardive Dyskinesia by administering a dopaminergic agent to the subject such that the dopaminergic agent enters the brain or by...
|
|
|
5280034 |
Bis-heterocyclic prostaglandin analogs
Thromboxane receptor antagonist activity is exhibited by compounds of the formula ##STR1## wherein: W is --(CH2)m -- or ##STR2## but if R3 and R4 complete an aromatic ring, then W cannot be...
|
|
|
5278148 |
Amino acid derivatives useful for treating high blood pressure
Compounds of the formula ##STR1## wherein R1 is hydrogen or methyl, R2 is ethyl, propyl, isopropyl, imidazol-2-yl, imidazol-4-yl, pyrazol-3-yl, thiazol-4-yl, thien-2-yl, ethoxycarbonyl,...
|
|
|
5276018 |
Composition comprising amino acids and methods for decreasing muscle breakdown
The present invention provides compositions and methods for decreasing tissue breakdown in mammals. Specifically, tissue breakdown in a mammal can be decreased by the administration of composition,...
|
|
|
5273984 |
Salts formed between basic histamine H2 -receptor antagonists and bismuth complexes
The invention relates to salts formed between basic H2 -receptor antagonists and a complex of bismuth with a carboxylic acid, and solvates of such salts, excluding salts in which the basic H2...
|
|
|
5273993 |
Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals
Methods of treating chronic arthritis and osteoporosis which utilize both known and novel compounds which would fall under the general formula: (HO)p--A--[--OS(O)2 NR1 R2 ]zwherein A encompasses a...
|
|
|
5273991 |
Imidazole-containing compositions and methods of use thereof analogs of distamycin
The present invention relates to oligopeptide derivatives that are conjugated to DNA alkylating agents, having the formula ##STR1## wherein m is 0 to 4; n is 2 to 4; each R1 is the same or...
|
|
|
5272176 |
Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use
The present invention relates to compositions and methods for inhibiting nonenzymatic cross-linking (protein aging). Accordingly, a composition is disclosed which comprises an agent capable of...
|
|
|
5266585 |
Arylphenyl ether derivatives, compositions containing these compounds and use thereof
Arylphenyl ether derivatives of the formula ##STR1## wherein Az is 1H-(1,2,4-triazolyl) or is 1-imidazolyl optionally substituted by alkyl, each of Ra and Rb is hydrogen, halogen, alkyl, alkoxy or...
|
|
|
5266318 |
Skin therapeutic mixture containing cold-processsed aloe vera extract, with yellow sap and aloin removed
According to present invention, a non-ionic skin therapeutic mixture useful for treatment of irradiated skin, open sores, wounds and abrasions is comprised of an extract of cold-processed aloe vera...
|
|
|
5264441 |
Disubstituted ureas and thioureas derivatives
The invention provides new ureas and thioureas derivatives of general formula (I) ##STR1## and pharmaceutically acceptable salts thereof, which are useful as therapeutic agents such as for the...
|
|
|
5260048 |
Tissue fixative solution and method
A tissue fixative solution and method is disclosed which comprises a histological fixing composition of diazolidinyl urea, 2-bromo-2-nitropropane-1,3-diol and a water-soluble zinc salt such as zinc...
|
|
|
5258398 |
Antithrombotic diaminoalkanoic acid derivatives
This invention relates to novel diaminoalkanoic acid derivatives that inhibit platelet aggregation and thrombus formation in mammalian blood thereby being useful in the prevention and treatment of...
|
|
|
5256657 |
Succinamide derivative matrix-metalloprotease inhibitors
Compounds having the structural formula ##STR1## wherein X is HONH or HO and especially wherein the carbon atom bearing CH2 R1 has the R-configuration, the carbon atom bearing CH2 R2 has the...
|
|
|
5248689 |
Substituted N-(imidazolyl)alkyl alanine derivatives
Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma,...
|
|
|
5246959 |
Poly(aminoalkyl)aminocarbonyl aminoacyl aminodiol amino acid derivatives as anti-hypertensive agents
Non-peptidyl compounds characterized generally as poly(aminoalkyl)aminocarbonyl aminoacyl aminodiol derivatives of amino acids are useful as renin inhibitors for the treatment of hypertension....
|
|
|
5240940 |
Quinoline and cinnoline fungicide compositions
Fungicidal compositions comprise a combination of two fungicides, one of which is a quinoline or cinnoline compound of the formula (1) ##STR1## the substituents being as described in the...
|
|
|
5238931 |
Inflammatory bowel disease preventive and curative agent containing zinc L-carnosine salt as active ingredient
An agent for the prevention and treatment of inflammatory bowel disease (IBD) containing at least one of zinc L-carnosine salts and complexes as an active ingredient. A use of the zinc L-carnosine...
|
|
|
5236928 |
Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists
There are disclosed substituted imidazole derivatives of Formula I bearing acidic functional groups which are useful as angiotensin II antagonists. ##STR1##
|
|
|
5234917 |
Substituted 5-(alkyl)carboxamide imidazoles
Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma...
|
|
|
5234939 |
3,5-di-tertiary-butyl-4-hydroxyphenyl imidazolyl methanones and related compounds as antiinflammatory agents
The novel 3,5-di-tertiary-butyl 4-hydroxyphenylimidazolyl methanones and methanone oximes of the present invention are antiinflammatory agents having activity as inhibitors of 5-lipoxygenase,...
|
|
|
5229369 |
Aminoalkylaminocarbonyl aminodiol amino acid derivatives as anti-hypertensive agents
Non-peptidyl compounds characterized generally as aminoalkylaminocarbonyl aminodiol derivatives of amino acids are useful as renin inhibitors for the treatment of hypertension. Compounds of...
|
|
|
5229137 |
Methods and pharmaceutical compositions for treating episodic heartburn
Pharmaceutical medications and methods are disclosed for providing instant and sustained relief from pain or symptoms associated with episodic heartburn in humans. The medications consist...
|
|
|
5223525 |
Pesticidal 1-arylimidazoles
The invention describes novel 1-arylimidazoles of formula (I) ##STR1## wherein typically preferred substituents are: X is S(O)n R1, in which R1 is an alkyl group, preferably a methyl group, which...
|
|
|
5221688 |
Imidazole derivatives
The invention relates to salts formed between basic H2 -receptor antagonists and a complex of zinc with a carboxylic acid selected from tartaric acid, citric acid and alkyl citric acids, and to...
|
|
|
5219870 |
Omeprazole compositions designed for administration in rectum
This invention relates to omeprazole compositions designed for administration in the rectum, wherein said compositions comprise omeprazole, an active ingredient, a mixture of polyethylene glycols...
|
|
|
5217986 |
Anti-allergy agent
The compound of the formula ##STR1## is described. This compound is active in an H3 receptor assay and is an H3 antagonist. Accordingly, the compound of formula I is useful in the treatment of...
|
|
|
5216003 |
Diacid-containing benzimidazole compounds for treatment of neurotoxic injury
A class of diacid-containing benzimidazole compounds is described for treatment to reduce neurotoxic injury associated with anoxia or ischemia which typically follows stroke, cardiac arrest or...
|
|
|
5214063 |
4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors
A compound of formula (I): ##STR1## in which R, R1 and R2 are as defined in the description. Medicinal product, which is useful in treating disorders related to a dysfunction of GABAB receptors.
|
|
|
5214064 |
Phenoxyphenylmethyl substituted azoles and pesticidal composition thereof
N-substituted azoles of the formula I ##STR1## where R1, R2, R3 are each hydrogen, halogen, C1 -C8 -alkyl, C1 -C8 -alkoxy, C1 -C4 -haloalkyl, C1 -C4 -haloalkoxy, C3 -C10 -cycloalkyl, nitro or...
|
|
|
5208234 |
Substituted imidazole phosphonic and phosphinic acid derivatives
Novel compounds having the formula ##STR1## wherein R1, R2, R3, R4 and R5 are as defined herein. These compounds inhibit the action of angiotensin II and are useful, therefore, for example, as...
|
|
|
5206257 |
Pesticidal method using 2-phenylimidazole derivatives
The invention provides a method for the control of arthropod, plant nematode, helminth or protozoan pests using a 2-phenylimidazole derivative of the formula: ##STR1## wherein R1 represents...
|
|
|
5204352 |
Compounds exhibiting anti-parasitic activity and a method for their use
Novel compounds are provided which exhibit high levels of anti-parasitic activity, specifically against parasites of the genus Trypanosoma. The compounds are comprised of aryl-substituted...
|
|
|
5196454 |
Method of treating disorders of the dopaminergic systems using 2,5-diaminotetralines
The invention relates to novel 2,5-diaminotetralines of the formula: ##STR1## wherein R1, R2, R3 and R4 are defined herein, processes for preparing them and their use in pharmaceutical...
|